VCM
NVAX icon

Voleon Capital Management’s Novavax NVAX Stock Holding History

Voleon Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
123,555
+4,803
+4% +$43.5K 0.02% 439
2025
Q4 		$798K Buy
+118,752
New +$895K 0.02% 482

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voleon Capital Management's NVAX Position: Q1 2026 in Review

Voleon Capital Management increased its Novavax (NVAX) stake by 4% in Q1 2026, buying an estimated $43.5K and bringing the position to 123,555 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #439.

Voleon Capital Management first reported a position in NVAX in Q4 2025 and has held it in 2 quarters since. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Voleon Capital Management held 123,555 shares of Novavax worth $1.01M as of Q1 2026.
  • Voleon Capital Management bought 4,803 Novavax shares in Q1 2026, an estimated $43.5K.
  • Novavax made up 0.02% of Voleon Capital Management's portfolio in Q1 2026, its #439 holding.
  • Voleon Capital Management first reported a position in Novavax in Q4 2025 and has held it in 2 quarters since.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.